E3 ubiquitin-protein ligase that may mediate ubiquitination of MHC-I, CD4 and ICAM1, and promote their subsequent endocytosis and sorting to lysosomes via multivesicular bodies. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfer the ubiquitin to targeted substrates.
KLH conjugated synthetic peptide derived from human MARCH9 201-300/346
Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4℃.
0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Protein A affinity purified.
Golgi apparatus membrane; Multi-pass membrane protein. Lysosome membrane; Multi-pass membrane protein.
SwissProt: Q86YJ5 Human
- E3 ubiquitin protein ligase MARCH9
- MARCH IX
- Membrane associated RING CH protein IX
- membrane associated ring finger (C3HC4) 9
- Membrane associated RING finger protein 9
- RING finger protein 179
Fig1: Blank control: Hela(blue), the cells were fixed with 2% paraformaldehyde (10 min)
Isotype Control Antibody: Rabbit IgG(orange) ; Secondary Antibody: Goat anti-rabbit IgG-FITC(white blue), Dilution: 1:200 in 1 X PBS containing 0.5% BSA ; Primary Antibody Dilution: 1μg in 100 μL 1X PBS containing 0.5% BSA(green).
Fig2: Sample: MCF-7 (human)cell Lysate at 40 ug
Primary: Anti- MARCH9(ER1903-04)at 1/300 dilution
Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution
Predicted band size: 38kD
Observed band size: 38 kD
using Anti-MARCH9 antibody? Please let us know so
that we can cite the reference in this datasheet.
Choose your product,application and species below,then click
On the next page you can complete and submit your review.
Leave us a review
To our knowledge, customised protocols are not required for this product.
Please try the standard protocols listed below and let us know how you
Click here to view the